Glycosmedia - an international diabetes news service from the UK
  
 
Archived News
October 4th 2008
 
 
  Euro Consumer Diabetes Index 2008
  The Euro Consumer Diabetes Index provides the first ranking of European diabetes healthcare services across five key areas: Information, Consumer Rights and Choice; Generosity, Prevention; Access to Procedures and Outcomes. 55-page PDF (Health Consumer Powerhouse)
   
  If you have diabetes, go to Denmark!
  Denmark is the overall winner in the Euro Consumer Diabetes Index 2008, launched today in Brussels during a press conference hosted by the (Health Consumer Powerhouse)
   
  First patients to test diabetes vaccine
  The Swedish company Diamyd Medical declares that the first ten per cent in a phase III study of Diamyd diabetes vaccine are screened (Biotech Scandinavia)
   
  More exercise needed to tackle child obesity
  To maintain good health and stave off obesity and other serious illness in later life, it is recommended that children engage in at least 60 minutes of moderate to vigorous physical activity every day (BMA, UK)
   
  Backpacker with diabetes launches Diabetes UK into world of blogs
  Josh, in his early twenties with Type 1 diabetes, is travelling the Trans Siberian Express, via St Petersburg (Pictured), on to Thailand and beyond. He will be giving us regular accounts of his travels and how he has managed his diabetes whilst travelling (Diabetes UK)
   
  Pfizer alters focus in rush for new drugs
  Pfizer Inc. will abandon early stage research on heart drugs as part of a strategy to sharpen its focus on ailments such as cancer, Alzheimer's disease, and diabetes where the chances of a bigger profit are greatest (Boston Globe, USA)
   
  Focus on the World Diabetes Diagnostics Market
  This report analyzes the worldwide markets for Diabetes Diagnostics in Millions of US$ (Market Watch)
   
  Vessel Shrinkage as a Sign of Atherosclerosis Progression in Type 2 Diabetes Mellitus: A Serial Intravascular Ultrasound Analysis
  This serial IVUS study suggests that progression of coronary artery disease in patients with type II diabetes mellitus may be mainly attributed to vessel shrinkage (Diabetes)
   
  Interim results for a novel DNA plasmid BHT-3021 from a phase I/II type 1 diabetes study
  Bayhill Therapeutics is currently conducting a phase I/II study to evaluate safety and efficacy of its novel antigen-specific plasmid encoding human insulin BHT-3021 in type 1 diabetes (American Diabetes Association)
   
  GI News
  October 2008 edition (GI News, Australia)
   
  High Protein Diets- Do They Work??
  Study reveals that one significant contributing factor to keeping weight off is regular contact with health professionals (Diabetes In Control)
   
 
  
© Copyright Glycosmedia Partnership